Persistent Hotspots in Schistosomiasis Consortium for Operational Research and Evaluation Studies for Gaining and Sustaining Control of Schistosomiasis after Four Years of Mass Drug Administration of Praziquantel

類似資料

• Defining Persistent Hotspots: Areas That Fail to Decrease Meaningfully in Prevalence after Multiple Years of Mass Drug Administration with Praziquantel for Control of Schistosomiasis
  著者:: Kittur, Nupur, 等
  出版事項: (2017)
• Environmental Predictors of Schistosomiasis Persistent Hotspots following Mass Treatment with Praziquantel
  著者:: Walker, Joseph W., 等
  出版事項: (2020)
• Therapeutic efficacy and safety of praziquantel for intestinal schistosomiasis treatment among patients receiving rifampicin-based anti-TB drugs in the Lake Victoria zone, Tanzania
  著者:: Rajabu Hussein Mnkugwe, 等
  出版事項: (2025-09-01)
• Contributions of the Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) to Schistosomiasis Control and Elimination: Key Findings and Messages for Future Goals, Thresholds, and Operational Research
  著者:: Colley, Daniel G., 等
  出版事項: (2020)
• Five-Year Impact of Different Multi-Year Mass Drug Administration Strategies on Childhood Schistosoma mansoni–Associated Morbidity: A Combined Analysis from the Schistosomiasis Consortium for Operational Research and Evaluation Cohort Studies in the Lake Victoria Regions of Kenya and Tanzania
  著者:: Shen, Ye, 等
  出版事項: (2019)